|
1、关于用量的问题:表阿霉素单独用药时,成人剂量为按体表面积一次60~90mg/m2,联合化疗时,每次50~60mg/m2静脉注射。但也有用到120mg/m2的,根据病人血象可间隔21天重复使用。
2、关于配制使用的问题:(1)静脉注射,用灭菌注射用水稀释,使其终浓度不超过2mg/ml;(2)建议先注入生理盐水检查输液管通畅性及注射针头确实在静脉之后,再经此通畅的输液管给药。以此减少药物外溢的危险,并确保给药后静脉用生理盐水冲洗;(3)可用生理盐水或5%GS溶解稀释后静滴;(4)表阿霉素注射时溢出静脉会造成组织的严重损伤甚至坏死。小静脉注射或反复注射同一血管会造成静脉硬化。建议以中心静脉输注较好;(5)不可肌肉注射和鞘内注射。
相应的参考资料:
Epirubicin hydrochloride is given by intravenous injection of a solution in sodium chloride 0.9% or Water for Injections into a fast-running infusion of sodium chloride 0.9% or glucose 5% over 3 to 5 minutes, or by infusion over up to 30 minutes. It is given as a single agent in usual doses of 60 to 90 mg/m2 as a single dose every 3 weeks; this dose may be divided over 2 or 3 days if desired. A regimen of 12.5 to 25 mg/m2 once a week has also been tried in palliative care. High-dose regimens, of 120 mg/m2 or more every 3 weeks, or 45 mg/m2 for 3 consecutive days every 3 weeks have been used.
Doses may need to be reduced if epirubicin is given with other antineoplastics. Doses should also be reduced in patients with liver impairment (see ) and in those whose bone-marrow function is impaired by age or previous chemotherapy or radiotherapy.
A total cumulative dose of 0.9 to 1 g/m2 should not generally be exceeded, because of the risk of cardiotoxicity.
----Martindale 第35版 |
|